WESTBURY, N.Y.--(BUSINESS WIRE)--BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today launched LEUKOMAX XL, a new leukopak product that provides researchers with a minimum of 15 billion TNC. LEUKOMAX XL features the most cells from a single donor collection per volume, including over 50% more cells per bag than the standard Leukopak Full Paks, and is available through U.S. and U.K. collection sites. "BioIVT is proud to provide direct ac
BioIVT is a New York-based biotechnology company that provides biospecimen products and research services for life sciences and pharmaceutical companies.